- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04254900
Energy Availability in Male and Female Elite Wheelchair Athletes Over Seven Consecutive Training Days
March 30, 2020 updated by: Swiss Paraplegic Centre Nottwil
Energy Availability in Wheelchair Athletes
Low energy availability (LEA) is a major problem in sports as athletes ingest often a lower amount of energy compared to their actual needs.
The availability of energy is calculated based on their daily energy intake and the energy cost of the daily training sessions in relation to their fat-free mass.
Based on this calculation, it is known how much energy will available for the body (beside the fuel for training) to keep it in optimal physiological functioning.
It has been shown, that LEA occurs very often in female athletes, in endurance athletes as well as athletes in weight-sensitive sports (i.e.
jockeys, combat sports, gymnastics, ballet).
The purpose of this study was to investigate, whether LEA is a problem in wheelchair athletes as well.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Energy availability will be assessed over 7 consecutive training days using a dietary and training record as well as the Leisure Time PHysical Activity Questionnaire for spinal cord injury.
Resting Energy expenditure will be measured as well as body composition (by a DXA) before the start of data collection.
Study Type
Observational
Enrollment (Actual)
14
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lucerne
-
Nottwil, Lucerne, Switzerland, 6207
- Swiss Paraplegic Centre
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Elite wheelchair athletes from national team in different wheelchair sports
Description
Inclusion Criteria:
- athletes from a national team in wheelchair sports
Exclusion Criteria:
- unable to follow normal training routine
- unable to record diet or training
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Male wheelchair athletes
Other
|
energy availability will be determined by measuring energy intake, exercise energy expenditure and fat-free mass and using the following formula: energy availability = (energy intake - exercise energy expenditure) / fat-free mass
|
|
Female wheelchair athletes
Other
|
energy availability will be determined by measuring energy intake, exercise energy expenditure and fat-free mass and using the following formula: energy availability = (energy intake - exercise energy expenditure) / fat-free mass
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
energy availability
Time Frame: 7 consecutive days during pre-season
|
energy availability = (energy intake - exercise energy expenditure) / fat-free mass.
Energy intake and exercise energy expenditure are measured using a food and training diary.
The fat-free mass will be measured using a DXA scan.
|
7 consecutive days during pre-season
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joelle Flueck, PhD, Swiss Paraplegic Centre
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2019
Primary Completion (Actual)
March 1, 2020
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
February 3, 2020
First Submitted That Met QC Criteria
February 3, 2020
First Posted (Actual)
February 5, 2020
Study Record Updates
Last Update Posted (Actual)
March 31, 2020
Last Update Submitted That Met QC Criteria
March 30, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 2018-35
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.